Neumora Therapeutics to Participate in Upcoming Conferences in September

Core Insights - Neumora Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for brain diseases through novel mechanisms of action [3] Company Participation in Conferences - The company will participate in three investor conferences in September 2025, including one-on-one meetings and a fireside chat [4] - Specific conferences include the Wells Fargo Healthcare Conference on September 4, the Morgan Stanley Annual Global Healthcare Conference on September 8, and the H.C. Wainwright Annual Global Investment Conference on September 9 [4] Therapeutic Pipeline - Neumora's pipeline consists of seven programs targeting a range of underserved and prevalent diseases [3] - The company's mission is to redefine neuroscience drug development to improve treatment outcomes and quality of life for patients [3]